3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
13
Stage I Prostate Adenocarcinoma AJCC v7
1
Prostate Adenocarcinoma
1
Interventions
luprolide acetate gel depot
3
Magnetic Resonance Spectroscopy
3
Specimen Handling
2
Leuprolide
2
Goserelin
2
Biopsy
2
relugolix
1
radium Ra 223 dichloride
1
niraparib
1
gallium 68 PSMA-11
1
fluciclovine F-18
1
flibanserin
1
enzalutamide
1
atezolizumab
1
apalutamide
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abiraterone
1
X-Rays
1
Triptorelin Pamoate
1
Radium-223
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Prednisone
1
PROSTVAC
1
Methods
1
Lymph Node Excision
1
Glutamate Carboxypeptidase II
1
Estramustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Prostate Adenocarcinoma
×
PROSTVAC
×
Clear all
NCT04020094
2021-09-22
AtezoVax
University of Utah
Phase 2
Withdrawn